Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

I recently interviewed investor and author Daniel Rasmussen for The Long View podcast, where he commented that ''value hasn't worked in the U.S., but it's worked fine internationally.'' ...

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

Aspiration is terrific, but Labour's bravado about Britain being the fastest growing economy in the G7 was always hooey.

Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...

Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company ...

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted th ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Aradhana Sarin, AstraZeneca CFO, says the company is making a significant commitment to the U.S., explaining that the ...

CS Venkatakrishnan (pictured) said increasing taxes for banks - or other important sectors of the economy - won't help boost ...